2020-09311. GNT USA, Inc.; Filing of Color Additive Petition  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notification of petition.

    SUMMARY:

    The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, Inc. (GNT), proposing that the color additive regulations be amended to expand the safe use of spirulina (Arthrospira platensis) extract at levels consistent with good manufacturing practice.

    DATES:

    The color additive petition was filed on February 21, 2020.

    ADDRESSES:

    For access to the docket to read background documents or comments received, go to https://www.regulations.gov and insert the docket number found in brackets in the heading of this document into the “Search” box and follow the prompts, and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Stephanie A. Hice, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 301-348-1740.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under the Federal Food, Drug, and Cosmetic Act section 721(d)(1) (21 U.S.C. 379e(d)(1))), we are giving notice that we have filed a color additive petition (CAP 0C0316), submitted by GNT, c/o Hogan Lovells US LLP, 555 13th St. NW, Washington, DC 20004. The petition proposes to amend the color additive regulations in 21 CFR 73.530 Spirulina extract to expand the use of spirulina (Arthrospira platensis) extract to include alcoholic beverages, non-alcoholic beverages, condiments and sauces, dips, plant-based products, salad dressings, and seasoning mixes at levels consistent with good manufacturing practice.Start Printed Page 27341

    We have determined under 21 CFR 25.32(k) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.

    Start Signature

    Dated: April 28, 2020.

    Lowell J. Schiller,

    Principal Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2020-09311 Filed 5-7-20; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
05/08/2020
Department:
Food and Drug Administration
Entry Type:
Proposed Rule
Action:
Notification of petition.
Document Number:
2020-09311
Dates:
The color additive petition was filed on February 21, 2020.
Pages:
27340-27341 (2 pages)
Docket Numbers:
Docket No. FDA-2020-C-1309
PDF File:
2020-09311.pdf
CFR: (1)
21 CFR 73